Nasdaq · CIK 0001674416
CRSP CRISPR Therapeutics AG
Insider trading from SEC Form 4. Last filing 4 d ago. Close $53.39 on Oct 9, 2026, +20% from the 52-week low and -29% from the high.
Last 90 days
Net insider value
-$1.5M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
3
$1.5M by 2 insiders
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
CRSPOct 9, 2026 · close 53.39
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CRISPR Therapeutics AG, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | James R. Kasinger General Counsel and Secretary sell | $119k 1,990 shares | -2% | +22% from low-30% from high | |
| 8Weak | James R. Kasinger General Counsel and Secretary sell | $626k 10,400 shares | -10% | +33% from low-23% from high | |
| 40Moderate | Ali Behbahani director sell | $781k 13,679 shares | -45% | - | |
| 32Weak | Samarth Kulkarni Chief Executive Officer sell | $761k 13,081 shares | -6% | +84% from low-15% from high | |
| 54Moderate | Douglas A Treco director buy | $1.1M 20,000 shares | +1000% | +80% from low-17% from high | |
| 50Moderate | Simeon George director buy | $51M 989,812 shares | +1567% | +76% from low-8% from high | |
| 21Weak | Naimish Patel Chief Medical Officer sell | $141k 3,932 shares | -39% | +18% from low-33% from high | |
| 33Weak | Julianne Bruno Chief Operating Officer sell | $71k 1,714 shares | -14% | - | |
| 26Weak | James R. Kasinger General Counsel and Secretary sell | $131k 3,185 shares | -4% | - | |
| 36Weak | Raju Prasad Chief Financial Officer sell | $91k 2,197 shares | -12% | - | |
| 41Moderate | Samarth Kulkarni Chief Executive Officer sell | $414k 10,031 shares | -5% | - | |
| 38Weak | Raju Prasad Chief Financial Officer sell | $157k 3,762 shares | -23% | - | |
| 32Weak | Julianne Bruno Chief Operating Officer sell | $59k 1,388 shares | -15% | - | |
| 26Weak | James R. Kasinger General Counsel and Secretary sell | $169k 3,966 shares | -5% | - | |
| 45Moderate | Samarth Kulkarni Chief Executive Officer sell | $616k 14,435 shares | -8% | - | |
| 37Weak | John Greene director buy | $314k 7,000 shares | - | - | |
| 45Moderate | Samarth Kulkarni Chief Executive Officer sell | $1.0M 18,360 shares | -10% | - | |
| 20Weak | Julianne Bruno Chief Operating Officer sell | $18k 333 shares | -5% | - | |
| 30Weak | Samarth Kulkarni Chief Executive Officer sell | $1.0M 18,568 shares | -9% | - | |
| 40Moderate | James R. Kasinger General Counsel and Secretary sell | $619k 11,542 shares | -14% | - | |
| 28Weak | Samarth Kulkarni Chief Executive Officer sell | $827k 15,000 shares | -8% | - | |
| 35Weak | Samarth Kulkarni Chief Executive Officer sell | $1.7M 30,000 shares | -13% | - | |
| 30Weak | Samarth Kulkarni Chief Executive Officer sell | $199k 4,293 shares | -2% | - | |
| 15Weak | James R. Kasinger General Counsel and Secretary sell | $50k 1,089 shares | -2% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares10b5-1 | +1,990 | $13.62 | $27k | 96,774 | 4 d ago |
| Oct 6, 2026 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares10b5-1 | -1,990 | $60.04 | $119k | 94,784 | 4 d ago |
| Oct 6, 2026 | James R. Kasinger General Counsel and Secretary | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,990 | $0.00 | $0 | 81,242 | 4 d ago |
| Sep 22, 2026 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares10b5-1 | +10,400 | $13.62 | $142k | 105,184 | 18 d ago |
| Sep 22, 2026 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares10b5-1 | -10,400 | $60.24 | $626k | 94,784 | 18 d ago |
| Sep 22, 2026 | James R. Kasinger General Counsel and Secretary | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,400 | $0.00 | $0 | 83,232 | 18 d ago |
| Sep 17, 2026 | Ali Behbahani director | MOption exercise Common Shares | +30,000 | $14.00 | $420k | 30,316 | 21 d ago |
| Aug 6, 2025 | Ali Behbahani director | JOther Common Shares | +60 | $0.00 | $0 | 316 | 21 d ago |
| Sep 17, 2026 | Ali Behbahani director | SOpen-market sale Common Shares | -13,679 | $57.09 | $781k | 16,637 | 21 d ago |
| Aug 6, 2025 | Ali Behbahani director | JOther Common Sharesindirect: See Note 3 | +15 | $0.00 | $0 | 29 | 21 d ago |
| Sep 17, 2026 | Ali Behbahani director | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | 21 d ago |
| Sep 17, 2025 | Samarth Kulkarni Chief Executive Officer | GGift Common Shares | -6,000 | $0.00 | $0 | 201,004 | Sep 19, 2025 |
| Aug 16, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares | +25,000 | - | - | 220,085 | Aug 19, 2025 |
| Aug 18, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares | -13,081 | $58.15 | $761k | 207,004 | Aug 19, 2025 |
| Aug 16, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -25,000 | - | - | 0 | Aug 19, 2025 |
| Aug 6, 2025 | Douglas A Treco director | POpen-market purchase Common Shares | +20,000 | $57.03 | $1.1M | 22,000 | Aug 8, 2025 |
| Jul 16, 2025 | Simeon George director | POpen-market purchase Common Sharesindirect: See Note 1 | +6,510 | $52.03 | $339k | 69,687 | Jul 17, 2025 |
| Jul 16, 2025 | Simeon George director | POpen-market purchase Common Sharesindirect: See Note 2 | +22,319 | $52.03 | $1.2M | 238,897 | Jul 17, 2025 |
| Jul 16, 2025 | Simeon George director | POpen-market purchase Common Sharesindirect: See Note 3 | +960,983 | $52.03 | $50M | 1,730,179 | Jul 17, 2025 |
| Jun 5, 2025 | Maria Fardis director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Ali Behbahani director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Katherine A High director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Sandesh Mahatme director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | John Greene director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Christian Rommel director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Harold Edward Fleming director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Douglas A Treco director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Briggs Morrison director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Jun 5, 2025 | Simeon George director | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| May 30, 2025 | Naimish Patel Chief Medical Officer | AGrant or award Restricted Stock Unitsderivative | +25,000 | $0.00 | $0 | 25,000 | Jun 3, 2025 |
| May 30, 2025 | Raju Prasad Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Jun 3, 2025 |
| May 28, 2025 | Naimish Patel Chief Medical Officer | MOption exercise Common Shares | +10,000 | - | - | 10,000 | May 30, 2025 |
| May 29, 2025 | Naimish Patel Chief Medical Officer | SOpen-market sale Common Shares | -3,932 | $35.94 | $141k | 6,068 | May 30, 2025 |
| May 28, 2025 | Naimish Patel Chief Medical Officer | MOption exercise Restricted Stock Unitsderivative | -10,000 | - | - | 30,000 | May 30, 2025 |
| Mar 20, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Common Shares | +3,750 | - | - | 12,258 | Mar 24, 2025 |
| Mar 20, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares | +6,250 | - | - | 84,914 | Mar 24, 2025 |
| Mar 20, 2025 | Raju Prasad Chief Financial Officer | MOption exercise Common Shares | +6,250 | - | - | 18,964 | Mar 24, 2025 |
| Mar 20, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares | +19,688 | - | - | 205,116 | Mar 24, 2025 |
| Mar 21, 2025 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares | -3,185 | $41.23 | $131k | 81,729 | Mar 24, 2025 |
| Mar 21, 2025 | Julianne Bruno Chief Operating Officer | SOpen-market sale Common Shares | -1,714 | $41.23 | $71k | 10,544 | Mar 24, 2025 |
| Mar 21, 2025 | Raju Prasad Chief Financial Officer | SOpen-market sale Common Shares | -2,197 | $41.23 | $91k | 16,767 | Mar 24, 2025 |
| Mar 21, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares | -10,031 | $41.23 | $414k | 195,085 | Mar 24, 2025 |
| Mar 20, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Restricted Stock Unitsderivative | -6,250 | - | - | 18,750 | Mar 24, 2025 |
| Mar 20, 2025 | Raju Prasad Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -6,250 | - | - | 18,750 | Mar 24, 2025 |
| Mar 20, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -3,750 | - | - | 11,250 | Mar 24, 2025 |
| Mar 20, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -19,688 | - | - | 59,062 | Mar 24, 2025 |
| Mar 14, 2025 | Julianne Bruno Chief Operating Officer | AGrant or award Stock Option (Right to Buy)derivative | +36,666 | $0.00 | $0 | 36,666 | Mar 18, 2025 |
| Mar 14, 2025 | James R. Kasinger General Counsel and Secretary | AGrant or award Stock Option (Right to Buy)derivative | +36,666 | $0.00 | $0 | 36,666 | Mar 18, 2025 |
| Mar 14, 2025 | Samarth Kulkarni Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +110,000 | $0.00 | $0 | 110,000 | Mar 18, 2025 |
| Mar 14, 2025 | Naimish Patel Chief Medical Officer | AGrant or award Stock Option (Right to Buy)derivative | +46,667 | $0.00 | $0 | 46,667 | Mar 18, 2025 |
| Mar 14, 2025 | Raju Prasad Chief Financial Officer | MOption exercise Common Shares | +10,000 | - | - | 16,476 | Mar 18, 2025 |
| Mar 17, 2025 | Raju Prasad Chief Financial Officer | SOpen-market sale Common Shares | -3,762 | $41.80 | $157k | 12,714 | Mar 18, 2025 |
| Mar 14, 2025 | Julianne Bruno Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +27,500 | $0.00 | $0 | 27,500 | Mar 18, 2025 |
| Mar 14, 2025 | James R. Kasinger General Counsel and Secretary | AGrant or award Restricted Stock Unitsderivative | +27,500 | $0.00 | $0 | 27,500 | Mar 18, 2025 |
| Mar 14, 2025 | Samarth Kulkarni Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +82,500 | $0.00 | $0 | 82,500 | Mar 18, 2025 |
| Mar 14, 2025 | Naimish Patel Chief Medical Officer | AGrant or award Restricted Stock Unitsderivative | +32,500 | $0.00 | $0 | 32,500 | Mar 18, 2025 |
| Mar 14, 2025 | Raju Prasad Chief Financial Officer | MOption exercise Restricted Stock Unitsderivative | -10,000 | - | - | 20,000 | Mar 18, 2025 |
| Mar 14, 2025 | Raju Prasad Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +36,666 | $0.00 | $0 | 36,666 | Mar 18, 2025 |
| Mar 14, 2025 | Raju Prasad Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +27,500 | $0.00 | $0 | 27,500 | Mar 18, 2025 |
| Mar 10, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Common Shares | +2,399 | - | - | 9,461 | Mar 12, 2025 |
| Mar 10, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares | +5,500 | - | - | 80,380 | Mar 12, 2025 |
| Mar 10, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares | +19,250 | - | - | 190,863 | Mar 12, 2025 |
| Mar 11, 2025 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares | -2,850 | $42.42 | $121k | 77,530 | Mar 12, 2025 |
| Mar 11, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares | -9,973 | $42.42 | $423k | 180,890 | Mar 12, 2025 |
| Mar 11, 2025 | Julianne Bruno Chief Operating Officer | SOpen-market sale Common Shares | -1,198 | $42.42 | $51k | 8,263 | Mar 12, 2025 |
| Mar 11, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Common Shares | +435 | - | - | 8,698 | Mar 12, 2025 |
| Mar 11, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares | +2,250 | - | - | 79,780 | Mar 12, 2025 |
| Mar 11, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares | +9,000 | - | - | 189,890 | Mar 12, 2025 |
| Mar 12, 2025 | Julianne Bruno Chief Operating Officer | SOpen-market sale Common Shares | -190 | $43.32 | $8,231 | 8,508 | Mar 12, 2025 |
| Mar 12, 2025 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares | -1,116 | $43.32 | $48k | 78,664 | Mar 12, 2025 |
| Mar 12, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares | -4,462 | $43.32 | $193k | 185,428 | Mar 12, 2025 |
| Mar 10, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Restricted Stock Unitsderivative | -5,500 | - | - | 11,000 | Mar 12, 2025 |
| Mar 11, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Restricted Stock Unitsderivative | -2,250 | - | - | 0 | Mar 12, 2025 |
| Mar 10, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -2,399 | - | - | 4,796 | Mar 12, 2025 |
| Mar 10, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -19,250 | - | - | 38,500 | Mar 12, 2025 |
| Mar 11, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -435 | - | - | 0 | Mar 12, 2025 |
| Mar 11, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -9,000 | - | - | 0 | Mar 12, 2025 |
| Feb 26, 2025 | John Greene director | POpen-market purchase Common Shares | +7,000 | $44.85 | $314k | 7,000 | Feb 28, 2025 |
| Feb 19, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -18,360 | $55.21 | $1.0M | 171,613 | Feb 21, 2025 |
| Feb 18, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Common Shares | +650 | - | - | 7,395 | Feb 19, 2025 |
| Feb 18, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares10b5-1 | +13,250 | - | - | 208,541 | Feb 19, 2025 |
| Feb 16, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares | +20,000 | - | - | 82,597 | Feb 19, 2025 |
| Feb 19, 2025 | Julianne Bruno Chief Operating Officer | SOpen-market sale Common Shares | -333 | $52.80 | $18k | 7,062 | Feb 19, 2025 |
| Feb 18, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -11,640 | $55.05 | $641k | 196,901 | Feb 19, 2025 |
| Feb 18, 2025 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares | -9,595 | $53.85 | $517k | 73,002 | Feb 19, 2025 |
| Feb 19, 2025 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -6,928 | $52.80 | $366k | 189,973 | Feb 19, 2025 |
| Feb 18, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Common Shares | +3,825 | - | - | 76,827 | Feb 19, 2025 |
| Feb 19, 2025 | James R. Kasinger General Counsel and Secretary | SOpen-market sale Common Shares | -1,947 | $52.80 | $103k | 74,880 | Feb 19, 2025 |
| Feb 18, 2025 | Julianne Bruno Chief Operating Officer | MOption exercise Restricted Stock Unitsderivative | -650 | - | - | 650 | Feb 19, 2025 |
| Feb 18, 2025 | Samarth Kulkarni Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative10b5-1 | -13,250 | - | - | 13,250 | Feb 19, 2025 |
| Feb 16, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Restricted Stock Unitsderivative | -20,000 | - | - | 0 | Feb 19, 2025 |
| Feb 18, 2025 | James R. Kasinger General Counsel and Secretary | MOption exercise Restricted Stock Unitsderivative | -3,825 | - | - | 3,825 | Feb 19, 2025 |
| Dec 24, 2024 | Samarth Kulkarni Chief Executive Officer | MOption exercise Common Shares | +13,751 | $16.21 | $223k | 195,291 | Dec 27, 2024 |
| Dec 24, 2024 | Samarth Kulkarni Chief Executive Officer | MOption exercise Stock Option (Right to Buy)derivative | -13,751 | $0.00 | $0 | 0 | Dec 27, 2024 |
| Dec 2, 2024 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -15,000 | $55.10 | $827k | 181,540 | Dec 4, 2024 |
| Nov 11, 2024 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -23,121 | $55.43 | $1.3M | 203,419 | Nov 13, 2024 |
| Nov 11, 2024 | Samarth Kulkarni Chief Executive Officer | SOpen-market sale Common Shares10b5-1 | -6,879 | $56.27 | $387k | 196,540 | Nov 13, 2024 |
| Oct 16, 2024 | Samarth Kulkarni Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Oct 18, 2024 |
| Oct 16, 2024 | Julianne Bruno Chief Operating Officer | AGrant or award Stock Option (Right to Buy)derivative | +18,333 | $0.00 | $0 | 18,333 | Oct 18, 2024 |
| Oct 16, 2024 | Raju Prasad Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +18,333 | $0.00 | $0 | 18,333 | Oct 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Ali Behbahaniowner, director
- Julianne BrunoChief Operating Officer
- Maria Fardisdirector
- Harold Edward Flemingdirector
- Simeon Georgedirector, owner
- John Greenecfo, officer, director
- Katherine A Highdirector
- James R. KasingerGeneral Counsel and Secretary
- Samarth KulkarniChief Executive Officer
- Sandesh Mahatmedirector
- Briggs Morrisondirector
- Naimish PatelChief Medical Officer
- Raju PrasadChief Financial Officer
- Christian Rommeldirector
- Douglas A Trecoceo, officer, director, chair
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.